Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs

Rheumatology (Oxford). 2002 Mar;41(3):347-9. doi: 10.1093/rheumatology/41.3.347.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Azathioprine / therapeutic use
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Giant Cell Arteritis / drug therapy*
  • Giant Cell Arteritis / physiopathology
  • Health Status
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Methotrexate / therapeutic use
  • Pain / drug therapy
  • Pain / physiopathology
  • Pain Measurement
  • Prednisone / therapeutic use
  • Severity of Illness Index
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Azathioprine
  • Prednisone
  • Methotrexate